Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 476

1.

The Clinicopathological Spectrum of Acromegaly.

Akirov A, Asa SL, Amer L, Shimon I, Ezzat S.

J Clin Med. 2019 Nov 13;8(11). pii: E1962. doi: 10.3390/jcm8111962. Review.

2.

The Clinicopathological Spectrum of Parathyroid Carcinoma.

Akirov A, Asa SL, Larouche V, Mete O, Sawka AM, Jang R, Ezzat S.

Front Endocrinol (Lausanne). 2019 Oct 23;10:731. doi: 10.3389/fendo.2019.00731. eCollection 2019.

3.

Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D.

Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. Epub 2019 Oct 1. Review.

4.

Hypothalamic Endocrine Tumors: An Update.

Asa SL, Mete O.

J Clin Med. 2019 Oct 20;8(10). pii: E1741. doi: 10.3390/jcm8101741. Review.

5.

2020 Vision of Digital Pathology in Action.

Asa SL, Bodén AC, Treanor D, Jarkman S, Lundström C, Pantanowitz L.

J Pathol Inform. 2019 Aug 14;10:27. doi: 10.4103/jpi.jpi_31_19. eCollection 2019. No abstract available.

6.

A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology.

Singarayer R, Mete O, Perrier L, Thabane L, Asa SL, Van Uum S, Ezzat S, Goldstein DP, Sawka AM.

Endocr Pathol. 2019 Sep;30(3):201-218. doi: 10.1007/s12022-019-09585-2.

PMID:
31300997
7.

VEGFR-2 is downregulated in sestamibi-negative parathyroid adenomas.

Erovic BM, Goldstein DP, Asa SL, Janik S, Mete O, Irish JC.

Head Neck. 2019 Oct;41(10):3564-3569. doi: 10.1002/hed.25871. Epub 2019 Jul 10.

PMID:
31291025
8.

Treatment Options for Pancreatic Neuroendocrine Tumors.

Akirov A, Larouche V, Alshehri S, Asa SL, Ezzat S.

Cancers (Basel). 2019 Jun 14;11(6). pii: E828. doi: 10.3390/cancers11060828. Review.

9.

Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease.

Bongers PJ, Kluijfhout WP, Verzijl R, Lustgarten M, Vermeer M, Goldstein DP, Devon K, Rotstein LE, Asa SL, Brierley JD, Tsang RW, Ezzat S, Vriens MR, Mete O, Pasternak JD.

Ann Surg Oncol. 2019 Aug;26(8):2533-2539. doi: 10.1245/s10434-019-07444-2. Epub 2019 May 21.

PMID:
31115855
10.

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.

O'Kane GM, Ezzat S, Joshua AM, Bourdeau I, Leibowitz-Amit R, Olney HJ, Krzyzanowska M, Reuther D, Chin S, Wang L, Brooks K, Hansen AR, Asa SL, Knox JJ.

Br J Cancer. 2019 Jun;120(12):1113-1119. doi: 10.1038/s41416-019-0474-x. Epub 2019 May 20.

PMID:
31105270
11.

Characterization of Pancreatic Cancer Tissue Using Multiphoton Excitation Fluorescence and Polarization-Sensitive Harmonic Generation Microscopy.

Tokarz D, Cisek R, Joseph A, Golaraei A, Mirsanaye K, Krouglov S, Asa SL, Wilson BC, Barzda V.

Front Oncol. 2019 Apr 17;9:272. doi: 10.3389/fonc.2019.00272. eCollection 2019.

12.

Ki67 Quantitative Interpretation: Insights using Image Analysis.

Volynskaya Z, Mete O, Pakbaz S, Al-Ghamdi D, Asa SL.

J Pathol Inform. 2019 Mar 8;10:8. doi: 10.4103/jpi.jpi_76_18. eCollection 2019.

13.

Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging.

Turk AT, Asa SL, Baloch ZW, Faquin WC, Fellegara G, Ghossein RA, Giordano TJ, LiVolsi VA, Lloyd R, Mete O, Rosai J, Suster S, Thompson LDR, Wenig BM.

Thyroid. 2019 May;29(5):619-624. doi: 10.1089/thy.2018.0286. Epub 2019 Apr 27.

PMID:
30913992
14.

Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.

Zhang D, Kim SSR, Kelly DF, Asa SL, Movassaghi M, Mareninov S, Yong WH, Cloughesy TF, Rodriguez FJ, McKeever P, Qian J, Li JY, Mao Q, Newell KL, Green RM, Welsh CT, Xiong Z, Heaney AP.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2395-2402. doi: 10.1210/jc.2018-02419.

PMID:
30722009
15.

The Current Histologic Classification of Thyroid Cancer.

Asa SL.

Endocrinol Metab Clin North Am. 2019 Mar;48(1):1-22. doi: 10.1016/j.ecl.2018.10.001. Review.

PMID:
30717895
16.

An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.

Alshaikh OM, Asa SL, Mete O, Ezzat S.

Endocr Pathol. 2019 Jun;30(2):118-127. doi: 10.1007/s12022-019-9568-5.

PMID:
30706322
17.

Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.

Tordjman KM, Greenman Y, Ram Z, Hershkovitz D, Aizenstein O, Ariel O, Asa SL.

Endocr Pathol. 2019 Mar;30(1):74-80. doi: 10.1007/s12022-018-9562-3.

PMID:
30610567
18.

Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid Lesion.

Alharbi N, Asa SL, Szybowska M, Kim RH, Ezzat S.

Front Endocrinol (Lausanne). 2018 Nov 1;9:641. doi: 10.3389/fendo.2018.00641. eCollection 2018.

19.

GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.

Mete O, Kefeli M, Çalışkan S, Asa SL.

Mod Pathol. 2019 Apr;32(4):484-489. doi: 10.1038/s41379-018-0167-7. Epub 2018 Nov 2.

PMID:
30390035
20.

Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease.

Asa SL, Ezzat S, Kelly DF, Cohan P, Takasumi Y, Barkhoudarian G, Heaney AP, Ridout R, Chik CL, Thompson LDR, Gentili F, Mete O.

Am J Surg Pathol. 2019 Feb;43(2):251-260. doi: 10.1097/PAS.0000000000001185.

PMID:
30379651
21.

An Unusual Salivary Gland Tumor Mimicking Papillary Thyroid Carcinoma: Mammary Analog Secretory Carcinoma.

Asa SL, Mete O.

Front Endocrinol (Lausanne). 2018 Sep 25;9:555. doi: 10.3389/fendo.2018.00555. eCollection 2018.

22.

The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations.

Asa SL, Ezzat S, Mete O.

J Clin Med. 2018 Sep 13;7(9). pii: E280. doi: 10.3390/jcm7090280. Review.

23.

Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.

Mete O, Alshaikh OM, Cintosun A, Ezzat S, Asa SL.

Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.

PMID:
30215160
24.

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, Busam KJ, de Krijger RR, Dietel M, El-Naggar AK, Fernandez-Cuesta L, Klöppel G, McCluggage WG, Moch H, Ohgaki H, Rakha EA, Reed NS, Rous BA, Sasano H, Scarpa A, Scoazec JY, Travis WD, Tallini G, Trouillas J, van Krieken JH, Cree IA.

Mod Pathol. 2018 Dec;31(12):1770-1786. doi: 10.1038/s41379-018-0110-y. Epub 2018 Aug 23.

25.

Retraction for Wei et al., "The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling".

Wei W, Liu W, Cassol CA, Zheng W, Asa SL, Ezzat S.

Mol Cell Biol. 2018 Jul 30;38(16). pii: e00298-18. doi: 10.1128/MCB.00298-18. Print 2018 Aug 15. No abstract available.

26.

Immunohistochemical Biomarkers in Thyroid Pathology.

Baloch Z, Mete O, Asa SL.

Endocr Pathol. 2018 Jun;29(2):91-112. doi: 10.1007/s12022-018-9532-9. Review.

PMID:
29744727
27.

Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Mete O, Asa SL, Giordano TJ, Papotti M, Sasano H, Volante M.

Endocr Pathol. 2018 Jun;29(2):137-149. doi: 10.1007/s12022-018-9525-8. Review.

PMID:
29542002
28.

Immunohistochemical Biomarkers in Pituitary Pathology.

Asa SL, Mete O.

Endocr Pathol. 2018 Jun;29(2):130-136. doi: 10.1007/s12022-018-9521-z. Review.

PMID:
29453601
29.

Epidemiology and biomarker profile of pituitary adenohypophysial tumors.

Mete O, Cintosun A, Pressman I, Asa SL.

Mod Pathol. 2018 Jun;31(6):900-909. doi: 10.1038/s41379-018-0016-8. Epub 2018 Feb 12.

30.

Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Trading Six for a Risky Half Dozen: Reply.

Parente DN, Bongers PJ, Verzijl R, Rotstein LE, Asa SL, Kluijfhout WP, Devon KM, Goldstein DP, Mete O, Pasternak JD.

World J Surg. 2018 Jul;42(7):2279. doi: 10.1007/s00268-018-4505-1. No abstract available.

PMID:
29396615
31.

The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

Lloyd RV, Asa SL, LiVolsi VA, Sadow PM, Tischler AS, Ghossein RA, Tuttle RM, Nikiforov YE.

Hum Pathol. 2018 Apr;74:1-4. doi: 10.1016/j.humpath.2017.12.027. Epub 2018 Jan 16. No abstract available.

PMID:
29339178
32.

What's new in pituitary pathology?

Asa SL, Mete O.

Histopathology. 2018 Jan;72(1):133-141. doi: 10.1111/his.13295. Review.

PMID:
29239033
33.

Endocrine pathology: past, present and future.

Asa SL, Mete O.

Pathology. 2018 Jan;50(1):111-118. doi: 10.1016/j.pathol.2017.09.003. Epub 2017 Nov 11. Review.

PMID:
29132721
34.

Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?

Hernandez-Prera JC, Machado RA, Asa SL, Baloch Z, Faquin WC, Ghossein R, LiVolsi VA, Lloyd RV, Mete O, Nikiforov YE, Seethala RR, Suster S, Thompson LD, Turk AT, Sadow PM, Urken ML, Wenig BM.

Thyroid. 2017 Dec;27(12):1498-1504. doi: 10.1089/thy.2017.0280. Epub 2017 Nov 7.

PMID:
29020884
35.

The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary.

Shen Z, Asa SL, Ezzat S.

Mol Cell Endocrinol. 2018 Feb 5;461:188-193. doi: 10.1016/j.mce.2017.09.013. Epub 2017 Sep 14.

PMID:
28919299
36.

Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma.

Mete O, Gucer H, Kefeli M, Asa SL.

Am J Surg Pathol. 2018 Feb;42(2):201-213. doi: 10.1097/PAS.0000000000000943.

PMID:
28877067
37.

Integrated Pathology Informatics Enables High-Quality Personalized and Precision Medicine: Digital Pathology and Beyond.

Volynskaya Z, Chow H, Evans A, Wolff A, Lagmay-Traya C, Asa SL.

Arch Pathol Lab Med. 2018 Mar;142(3):369-382. doi: 10.5858/arpa.2017-0139-OA. Epub 2017 Aug 29.

PMID:
28849944
38.

Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?

Parente DN, Kluijfhout WP, Bongers PJ, Verzijl R, Devon KM, Rotstein LE, Goldstein DP, Asa SL, Mete O, Pasternak JD.

World J Surg. 2018 Feb;42(2):321-326. doi: 10.1007/s00268-017-4182-5.

PMID:
28828746
39.

Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin.

Alshaikh OM, Yoon JY, Chan BA, Krzyzanowska MK, Butany J, Asa SL, Ezzat S.

Endocr Pathol. 2018 Mar;29(1):15-20. doi: 10.1007/s12022-017-9492-5.

PMID:
28718084
40.

The epigenetic landscape of differentiated thyroid cancer.

Asa SL, Ezzat S.

Mol Cell Endocrinol. 2018 Jul 5;469:3-10. doi: 10.1016/j.mce.2017.07.012. Epub 2017 Jul 12. Review.

PMID:
28711609
41.

Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.

Ezzat S, Cheng S, Asa SL.

Mol Cell Endocrinol. 2018 Jul 5;469:70-76. doi: 10.1016/j.mce.2017.07.011. Epub 2017 Jul 12. Review.

PMID:
28711607
42.

Clinical Applications of Whole-slide Imaging in Anatomic Pathology.

Volynskaya Z, Evans AJ, Asa SL.

Adv Anat Pathol. 2017 Jul;24(4):215-221. doi: 10.1097/PAP.0000000000000153. Review.

PMID:
28590953
43.

The evolution of differentiated thyroid cancer.

Asa SL.

Pathology. 2017 Apr;49(3):229-237. doi: 10.1016/j.pathol.2017.01.001. Epub 2017 Mar 7. Review.

PMID:
28279477
44.

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N, Korbonits M, Laws ER Jr, Lopes MB, Maartens N, McCutcheon IE, Mete O, Nishioka H, Raverot G, Roncaroli F, Saeger W, Syro LV, Vasiljevic A, Villa C, Wierinckx A, Trouillas J; attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016.

Endocr Relat Cancer. 2017 Apr;24(4):C5-C8. doi: 10.1530/ERC-17-0004.

PMID:
28264912
45.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD.

Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.

46.

Pituitary acromegaly: not one disease.

Asa SL, Kucharczyk W, Ezzat S.

Endocr Relat Cancer. 2017 Mar;24(3):C1-C4. doi: 10.1530/ERC-16-0496. Epub 2017 Jan 25.

PMID:
28122798
47.

Xanthomatous Hypophysitis Is Associated with Ruptured Rathke's Cleft Cyst.

Duan K, Asa SL, Winer D, Gelareh Z, Gentili F, Mete O.

Endocr Pathol. 2017 Mar;28(1):83-90. doi: 10.1007/s12022-017-9471-x.

PMID:
28120170
48.

Pancreatic Struma with Papillary Thyroid Carcinoma: a Diagnostic Dilemma.

Liu J, Marcaccio MJ, Young JE, Aziz T, Wat J, Asa SL.

Endocr Pathol. 2017 Mar;28(1):91-94. doi: 10.1007/s12022-016-9462-3. No abstract available.

PMID:
28078619
49.

The dangers of parathyroid biopsy.

Kim J, Horowitz G, Hong M, Orsini M, Asa SL, Higgins K.

J Otolaryngol Head Neck Surg. 2017 Jan 7;46(1):4. doi: 10.1186/s40463-016-0178-7.

50.

Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases.

Karpathakis A, Dibra H, Pipinikas C, Feber A, Morris T, Francis J, Oukrif D, Mandair D, Pericleous M, Mohmaduvesh M, Serra S, Ogunbiyi O, Novelli M, Luong T, Asa SL, Kulke M, Toumpanakis C, Meyer T, Caplin M, Beck S, Thirlwell C.

Endocr Relat Cancer. 2017 Feb;24(2):L21-L25. doi: 10.1530/ERC-16-0419. Epub 2017 Jan 3. No abstract available.

PMID:
28049633

Supplemental Content

Support Center